Schistosomiasis has a hugely detrimental effect on a child's mental and physical development. By treating children we are giving them the opportunity to reach their full potential and live healthier, happier lives.
GSA and ISNTD monthly schistosomiasis focused webinar series, using the ISNTD Connect platform and the GSA expert network.
"Where can a 50-year career in schistosomiasis take you geographically and scientifically?", a conversation with Dr. Dan Colley (Professor Emeritus of Microbiology at the University of Georgia) & Dr. Goylette Chami (Nuffield Department of Population Health at the University of Oxford).
As schistosomiasis poses a threat to people of all ages, unfortunate gaps exist in current treatment coverage and associated monitoring efforts, preventing subsequent health benefits to preschool-aged children as well as certain adolescents and adults. Current omission of these age groups from treatment and monitoring exacerbates health inequities and has long-term consequences for sustainable schistosomiasis control.
Derick Osakunor, from the University of Edinburgh, discusses the current treatment gaps in different age groups and how these are hindering the schistosomiasis goal of "elimination as a public health problem".
GSA 2019 report and 2020 operational strategy.
June's edition of the Schisto Bulletin. News and updates from the schistosomiasis community.
ISNTD and GSA are collaborating on a ISNTD Connect GSA series, bringing you a schistosomiais webinar every month, starting with this Thursday 4th of June, a conversation with Dan Colley.
In this special edition of the Schisto Bulletin GSA parnters and stakeholders from the schistosomiasis community share the impact of Covid-19 and associated restrictions on schistosomiasis community.
March's edition of the Schisto Bulletin. News and updates from the schistosomiasis community.